As filed with the Securities and Exchange Commission on May 24, 2019
Registration No. 333-230536
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
to
FORM S-8
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
EQUILLIUM, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
82-1554746 |
(State or other jurisdiction of |
|
(I.R.S. Employer |
|
|
|
2223 Avenida de la Playa, Suite 105 La Jolla, California |
|
92037 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
2018 Equity Incentive Plan
2018 Employee Stock Purchase Plan
(Full titles of the plans)
Daniel M. Bradbury
Chief Executive Officer
Equillium, Inc.
2223 Avenida de la Playa, Suite 105
La Jolla, California 92037
(858) 412-5302
(Name, address, and telephone number, including area code, of agent for service)
Copies to:
Thomas A. Coll, Esq. Karen E. Anderson, Esq. Wade W. Andrews, Esq. Cooley LLP 4401 Eastgate Mall San Diego, California 92121 Tel: (858) 550-6000 |
|
Jason A. Keyes Chief Financial Officer Equillium, Inc. 2223 Avenida de la Playa, Suite 105 La Jolla, California 92037 (858) 412-5302 |
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer |
☐ |
|
Accelerated filer |
☐ |
Non-accelerated filer |
☒ |
|
Smaller reporting company |
☒ |
|
|
|
Emerging growth company |
☒ |
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
This Post-Effective Amendment No. 1 to Registration Statement on Form S-8 is being filed solely to correct certain of the exhibit hyperlinks contained in the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on March 27, 2019 (File No. 333-230536).
Item 8. Exhibits.
Exhibit |
|
Description |
4.1 |
|
|
|
|
|
4.2 |
|
|
|
|
|
4.3 |
|
|
|
|
|
5.1 |
|
|
|
|
|
23.1 |
|
|
|
|
|
23.2 |
|
|
|
|
|
24.1 |
|
|
|
|
|
99.1 |
|
|
|
|
|
99.2 |
|
|
|
|
|
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to Registration Statement on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of La Jolla, State of California, on May 24, 2019.
Equillium, Inc. |
||
|
|
|
By: |
/s/ Daniel M. Bradbury |
|
|
Daniel M. Bradbury |
|
|
Chief Executive Officer |
Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to Registration Statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ Daniel M. Bradbury |
|
Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) |
|
May 24, 2019 |
Daniel M. Bradbury |
|
|
|
|
|
|
|
|
|
/s/ Jason A. Keyes |
|
Chief Financial Officer (Principal Financial and Accounting Officer) |
|
May 24, 2019 |
Jason A. Keyes |
|
|
|
|
|
|
|
|
|
/s/ Bruce D. Steel* |
|
President, Chief Business Officer and Member of the Board of Directors |
|
May 24, 2019 |
Bruce D. Steel |
|
|
|
|
|
|
|
|
|
/s/ Stephen Connelly, Ph.D.* |
|
Chief Scientific Officer and Member of the Board of Directors |
|
May 24, 2019 |
Stephen Connelly, Ph.D. |
|
|
|
|
|
|
|
|
|
/s/ Martha J. Demski* |
|
Member of the Board of Directors |
|
May 24, 2019 |
Martha J, Demski |
|
|
|
|
|
|
|
|
|
/s/ Bala S. Manian, Ph.D.* |
|
Member of the Board of Directors |
|
May 24, 2019 |
Bala S. Manian, Ph.D. |
|
|
|
|
|
|
|
|
|
/s/ Charles McDermott* |
|
Member of the Board of Directors |
|
May 24, 2019 |
Charles McDermott |
|
|
|
|
|
|
|
|
|
/s/ Mark Pruzanski, M.D.* |
|
Member of the Board of Directors |
|
May 24, 2019 |
Mark Pruzanski, M.D. |
|
|
|
|
* Pursuant to power of attorney
|
|
|
|
|
|
By: |
|
/s/ Jason A. Keyes |
|
|
Jason Keyes Attorney-in-fact |